Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,870 total articles

Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

Weight Watchers Schedules First Quarter 2026 Earnings Conference Call

WW International, Inc., the leader in science-backed weight management, announced it will release its first quarter 2026 earnings before market open on May 7, 2026, followed by a conference call to discuss results. The company continues to emphasize its integrated, personalized weight management approach, including support for GLP-1 medications and…

Waterstone Financial, Inc. Announces Results of Operations for the Three Months Ended March 31, 2026

Waterstone Financial, Inc. Announces Results of Operations for the Three Months Ended March 31, 2026

Waterstone Financial, Inc. announced its Q1 2026 results, reporting net income of $6.0 million ($0.34 per diluted share), doubling from $3.0 million in Q1 2025. Growth was driven by expanded net interest margins, increased loan originations in its mortgage segment, and strong community banking performance. The company increased its quarterly divide…

IREN to Release Q3 FY26 Results on May 7, 2026

IREN to Release Q3 FY26 Results on May 7, 2026

IREN Limited, a vertically integrated AI cloud provider specializing in data centers and GPU clusters powered by renewable energy, will release its Q3 FY26 financial results on May 7, 2026, followed by a conference call with live Q&A for investors and analysts.

Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.

Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.

Regeneron Pharmaceuticals has reached an agreement with the U.S. government to reduce drug costs by aligning Medicaid and future medicine prices with those of other developed countries. As part of this agreement, Regeneron will provide its new gene therapy, Otarmeni™, free of charge in the U.S., and make cardiovascular drug Praluent® available for …

Magnera to Report Second Quarter Results on May 7th

Magnera to Report Second Quarter Results on May 7th

Magnera Corporation (NYSE: MAGN), a global materials solutions company, will release its Q2 2026 earnings before NYSE trading on May 7, 2026, followed by a detailed investor presentation and conference call. The company serves diverse sectors including hygiene, protective apparel, construction, and food & beverage industries across 45 facilities wo…

Teck Announces Dividend

Teck Announces Dividend

Teck Resources Limited announced a quarterly dividend of $0.125 per share payable on June 30, 2026, demonstrating the company's ongoing commitment to shareholder returns amid its focus on responsible growth in the mining sector. The dividend applies to both Class A common shares and Class B subordinate voting shares.

VivoPower Launches Lease Bidding after Receiving Strong Interest from AI Operators for 41.5MW Norway Data Center

VivoPower Launches Lease Bidding after Receiving Strong Interest from AI Operators for 41.5MW Norway Data Center

VivoPower PLC has launched a formal competitive bidding process to select tenants for its recently acquired 41.5MW data center in Mo i Rana, Norway. The facility, powered by low-cost renewable hydroelectric energy, is attracting strong interest from AI neocloud operators and hyperscalers. The lease selection aims to optimize commercial terms, opera…

Otarmeni™ (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the U.S.

Otarmeni™ (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the U.S.

Regeneron Pharmaceuticals, Inc. announced FDA accelerated approval of Otarmeni (lunsotogene parvec-cwha), the first and only gene therapy for severe-to-profound genetic hearing loss caused by OTOF gene variants. Based on the pivotal CHORD trial showing 80% of participants met the primary endpoint with significant hearing improvements, Otarmeni repr…

C&F Financial Corporation Announces Net Income for First Quarter

C&F Financial Corporation Announces Net Income for First Quarter

C&F Financial Corporation reported net income of $6.8 million for Q1 2026, up from $5.4 million in Q1 2025, driven by growth in the community banking and mortgage banking segments despite challenges in consumer finance. Results were supported by strong loan and deposit growth, a higher net interest margin, and a 58% increase in mortgage origination…

Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting

Catheter Precision to Attend and Share New Clinical Data at the 47th Annual Heart Rhythm Society Meeting

Catheter Precision, Inc., a US-based medical device company specializing in cardiac electrophysiology products, announced it will present new clinical data for its VIVO system at the 47th Annual Heart Rhythm Society meeting. The data highlights the system's ability to accurately localize ventricular arrhythmias using intracardiac electrograms, pote…

Westamerica Bancorporation Increases Quarterly Cash Dividend

Westamerica Bancorporation Increases Quarterly Cash Dividend

Westamerica Bancorporation announced a quarterly cash dividend increase of $0.02 per share to $0.48, reflecting the company's reliable earnings, financial strength, and conservative risk profile. This comes shortly after reporting a net income of $27.4 million for Q1 2026, demonstrating solid profitability. The dividend increase underscores confide…

Lee Enterprises plans quarterly call and webcast May 7, 2026

Lee Enterprises plans quarterly call and webcast May 7, 2026

Lee Enterprises announced it will hold a quarterly earnings conference call and webcast on May 7, 2026, to discuss preliminary results for the quarter ended March 29, 2026. The event is aimed at providing investors with updates on the company’s performance across its local news and subscription platform operations.

ACNB Corporation Reports 2026 First Quarter Financial Results

ACNB Corporation Reports 2026 First Quarter Financial Results

ACNB Corporation reported a net income of $13.7 million for Q1 2026, a significant turnaround from a net loss in Q1 2025, driven by improved profitability, stable asset quality, and balance sheet growth. Key highlights include strong loan and deposit growth, improved net interest margin, stable credit quality, and strategic share repurchases. The c…

National Healthcare Properties Announces Closing of Public Offering

National Healthcare Properties Announces Closing of Public Offering

National Healthcare Properties, Inc. successfully closed its public offering of 38.5 million Class A shares at $12.00 per share, with an over-allotment option of 5.775 million shares. The offering proceeds will be used primarily to repay $186 million of revolving credit facility debt, fund potential healthcare real estate acquisitions, and for gene…

Allsteel Unveils Newly Reimagined Boston Showroom Design

Allsteel Unveils Newly Reimagined Boston Showroom Design

Allsteel, a brand under HNI Corporation, has unveiled a redesigned showroom in Boston that emphasizes adaptable and human-centric workplace environments. The showroom features five experiential zones tailored to diverse workstyles and promotes inclusivity, sustainability, and flexibility in office design. This space aims to serve as a dynamic resou…

Trust Stamp and Partisia partner with Digital Platformer to Combine Biometric Tokenisation and MPC Technologies to Advance Decentralised Identity Solutions in Japan and the Region

Trust Stamp and Partisia partner with Digital Platformer to Combine Biometric Tokenisation and MPC Technologies to Advance Decentralised Identity Solutions in Japan and the Region

Trust Stamp (Nasdaq: IDAI) has entered a commercial agreement with Digital Platformer and Partisia to deploy a unified privacy-preserving biometric authentication solution integrating biometric tokenization and Multi-Party Computation (MPC) technology. This solution aims to advance digital identity verification, financial security, and privacy acro…

Actelis Networks Secures New Order for Alaska State Department of Transportation Intelligent Transportation System Project

Actelis Networks Secures New Order for Alaska State Department of Transportation Intelligent Transportation System Project

Actelis Networks, a provider of cyber-hardened hybrid fiber-copper networking solutions, announced a new order for the Alaska State Department of Transportation ITS project. This order supports upgrades to traffic signal and cabinet infrastructure in Anchorage using Actelis' technology that delivers fiber-grade connectivity over existing wiring, re…

36Kr Holdings Inc. Files 2025 Annual Report on Form 20-F

36Kr Holdings Inc. Files 2025 Annual Report on Form 20-F

36Kr Holdings Inc., a China-based platform serving New Economy participants, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission. The report is accessible to investors and contains audited consolidated financial statements. The company provides high-qual…

WeRide Inc. Files Its 2025 Annual Report on Form 20-F

WeRide Inc. Files Its 2025 Annual Report on Form 20-F

WeRide Inc., a pioneer in autonomous driving technology and the first publicly traded Robotaxi company, announced the filing of its 2025 annual report on Form 20-F with the SEC. The report covers their business operations, technology deployments in over 40 cities across multiple countries, and regulatory achievements including autonomous driving pe…